The group's principal activity is to provide research and development services. The group provides develop the chemical compound that make possible two-photon photodynamic therapy which can be an all-in-cancer detection and treatment solution, that, in an outpatient, non-surgical alternative to conventional cancer detection and therapy. The group operates from the United States.
